Latest Biotechnology, Pharmaceutical and Healthcare News
BioPortfolio’s biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 250 sources. BioPortfolio has content licence agreements with Businesswire, PRNewswire, Reuters etc and imports RSS feeds from leading authoritative publishers. Readers can search and track news using MyBioPortfolio, news categories, RSS, Daily Digest and our collection of 150+ Twitter accounts.
Ensure your news is published on BioPortfolio!
To add your organizations press releases, articles, white papers and blogs review our BioNewsCast service and purchase publishing credits. If you have an RSS feed you wish to submit to BioPortfolio contact peter.barfoot@bioportfolio.com.
Showing News Articles 1–25 of 370,000+
In 2012 Ewen Callaway travelled to Northern Nigeria to learn more about the global polio eradication effort. We join him on the search to find [...]
Women in childbirth still being denied their human rights
New research shows despite more than 50 years of campaigning, too many mothers are still being denied their human rights in childbirth.
Laughing gas does not increase heart attacks
(Medical Xpress)—Nitrous oxide—best known as laughing gas—is one of the world's oldest and most widely used anesthetics. Despite its popularity, however, experts have questioned its impact on the risk of a heart attack during surgery or soon af...
EU fines Lundbeck and others 146 million euros for blocking rival drugs
By Foo Yun Chee BRUSSELS (Reuters) - European antitrust regulators fined nine drugmakers, including Denmark's Lundbeck, a total of 146 million euros ($195 million) for blocking the supply of a cheaper anti-depressant to the market, the first EU sanct...
EU fines pharma firms over generics delay (Update)
(AP)—The European Union has fined Danish pharmaceuticals multinational Lundbeck and several other producers a combined 146 million euros ($195 million) for delaying the market entry of cheaper generic alternatives to a major antidepressant.
EU fines Denmark's Lundbeck 94 mn euros in generic drugs case
The EU executive on Wednesday imposed a fine of 93.8 million euros on Danish pharma firm Lundbeck for colluding with generics producers a decade ago to delay the sale of a cheap version of a popular anti-depressant.
Dallas, TX, June 19, 2013 --(PR.com)-- Rosellini Scientific is pleased to report the acquisition of Grey Owl Dental, LLC. Terms were not disclosed. The company will be operating under “Rosellini Scientific, Dental Division.” The acquisition enables Rosellini Scientific to deliver full-service dental care to nursing home patients in addition to providing a single point of contact for c...
Habla Espanol? No Hay Problema! says Co-Parenting Software Pioneer Kids On Time.
PORTLAND, Maine, June 19, 2013 /PRNewswire-iReach/ -- Kids On Time co-parenting tools announces today the availability of their life enhancing co-parenting program to the Spanish speaking market place. (Photo: http://photos.prnewswire.com/prnh/20130619/CG34685)Kids On Time is an online co-parenting program that enables parents to get organized, communicate better and participate more effect...
Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase
BIRMINGHAM, Ala., June 19, 2013 /PRNewswire/ -- DST Health Solutions, LLC (DSTHS), a leading provider of technology solutions and services to health plans, integrated delivery systems, and health care providers, has announced that demand for its Medical Drug Management Service (MDMS) has jumped significantly. A customizable solution used to clinically edit and automate the pricing of medical pres...
SAN JOSE, Calif., June 19, 2013 /PRNewswire/ -- BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD LSRFortessa™ X-20 Cell Analyzer, the latest in its line of high-performance research flow cytometers. The BD LSRFortessa X-20 Cell Analyzer delivers high-performance multicolor analysis...
CARLSBAD, Calif., June 19, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announces a licensing agreement granting Suzhou Ribo Life Sciences (Ribo) the exclusive rights to develop and manufacture siRNA therapeutics in China using Life's Invivofectamine® Rx delivery technology. Ribo will formulate proprietary siRNA molecules in combination with Inviv...
Survey: Americans Expect Schools to Lead in Preventing Childhood Obesity
OAKLAND, Calif., June 19, 2013 /PRNewswire/ -- Americans view obesity as a serious problem among both the overall public and among children and teens, and most people believe that local K-12 schools need to take a leading role in combating the epidemic, according to a recent survey conducted by Field Research Corp. Nationwide, 78 percent of parents think that healthier food in schools will...
FREMONT, Calif., June 19, 2013 /PRNewswire/ -- Smart Embedded Systems, a business unit of Abisys Corporation, a Silicon Valley-based Company, announced the availability of modules based on Sitara™ AM335x ARM® Cortex™-A8 processors from Texas Instruments Incorporated (TI). Smart Embedded Systems offers programmable real-time unit (PRU) firmware and Linux drivers for SoftU...
PRINCETON, N.J., June 19, 2013 /PRNewswire-iReach/ -- In its first major deal, Belrose Pharma, a new specialty pharmaceutical company dedicated to advancing development of the next generation of innovative injectable and sustained release drug therapies in patient disease populations with high unmet medical needs, today announced the acquisition of Enzon Pharmaceutical's PEGylation Linker Technolo...
South Shore Hospital Standardizes to Masimo SET® Pulse Oximetry for Improved Patient Monitoring
WEYMOUTH, Mass. and IRVINE, Calif., June 19, 2013 /PRNewswire/ -- Masimo (NASDAQ: MASI) and South Shore Hospital, ranked among the top three hospitals in Massachusetts by U.S. News & World Report (2012-13), jointly announce that South Shore Hospital has converted to Masimo SET® pulse oximetry and sensor technologies, used at leading health organizations worldwide. Masimo SET® p...
WHITE PLAINS, N.Y., June 19, 2013 /PRNewswire/ -- This year alone, The Leukemia & Lymphoma Society (LLS) is supporting more than 300 research projects with one goal in mind: Discovering lifesaving therapies for blood cancer patients. And in 2013, "Team In Training" (TNT), a flagship LLS fundraising campaign and the world's first and largest endurance sports training program, is marking it...
Actavis And Kissei File Lawsuits Against Sandoz And Hetero For Infringement Of Rapaflo® Patent
PARSIPPANY, N.J., June 19, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) and Kissei Pharmaceutical Co., LTD today confirmed that they have filed lawsuits against Sandoz Inc., Hetero USA, Inc., Hetero Labs Limited and Hetero Labs Limited, Unit III in the U.S. District Court for the District of Delaware for infringement of U.S. Patent No. 5,387,603 (the '603 patent) covering Rapaflo®, a t...
LAS VEGAS, June 19, 2013 /PRNewswire-USNewswire/ -- Weight Watchers International, Inc. and the United States Conference of Mayors will announce the three cities that have been selected as grant recipients of the Healthy Communities Grant Program, an initiative designed to help curb the national obesity epidemic and foster healthy lifestyles in communities, especially low-income areas that te...
NESS ZIONA, Israel, June 19, 2013 /PRNewswire/ -- NeuroDerm, Ltd. today announced that results from a phase I study in volunteers, and preliminary results from a phase IIA study in advanced Parkinson's patients, of ND0612, were presented at the 2013 International Congress of Parkinson's Disease and Movement Disorders. ND0612 is a proprietary levodopa/carbidopa liquid drug formula under developmen...
Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings
MOUNTAIN VIEW, Calif., June 19, 2013 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced that it was named the number one overall pharmacy equipment vendor in the KLAS 2013 Medical Equipment & Infrastructure Report. KLAS, a leading independent healthcare research fi...
New Profit And Deloitte Announce A New Strategic Collaboration To Drive Social Innovation
NEW YORK, June 19, 2013 /PRNewswire/ -- New Profit Inc. and Deloitte today announced a multi-million dollar collaboration to help fuel the social innovations that are dramatically improving opportunities for children, families, and communities. This initiative will support the growth and increase the impact of groundbreaking solutions in areas such as education, workforce development, public...
LONDON, June 19, 2013 /PRNewswire/ -- The U.S. Supreme Court last year upheld President Obama's Affordable Care Act (ACA), paving the way for the biggest overhaul of the U.S. healthcare sector in decades. The ACA goes into full effect next year. The reform has generally been welcomed by healthcare companies which expect to benefit from it in the long-term. One of the biggest beneficiaries of the...
Charity calls for ban of 'face-down restraint'
The use of physical restraint in psychiatric hospitals has been widely reported after the publication of a report by the mental health charity MIND on the use of the practice in England. The report said that last year almost 40,000 incidents of physical restraint were recorded, with almost 1,000 cases of physical injury after a patient had been physically restrained. MIND is particularly concern...
Model recreates wear and tear of osteoarthritis
(Medical Xpress)—There's a reason osteoarthritis is often called wear-and-tear arthritis: Repeated stress on joints over time results in degeneration of the soft cartilage that normally distributes loads to the joints.
NIH invests millions to unlock cupboards of shelved drugs
When 19th Century writer George Eliot said "It's never too late to be what you might have been," she likely was not thinking about new uses for old drugs.
